The latest call
FetchingTenon Medical, Inc reported on 12 de noviembre de 2026. We are fetching the call transcript; its summary follows once the transcript is in.
1,41 US$-21,2 %cierre 13 nov
The latest quarter (ended 30 de septiembre de 2026) is from Tenon Medical’s earnings press release of 12 de noviembre de 2026. It will be replaced by the official quarterly report (10-Q) once Tenon Medical files it.
| Medida | 3 meses hasta30 sept 2026 | 3 meses hasta30 sept 2025 | Variación |
|---|---|---|---|
| Ingresos totales | 1,4M US$ | 1,2M US$ | +22,08 % |
Estos son trimestres sueltos, no un año móvil: las cifras del resto del sitio cubren doce meses y serán mucho mayores. Un negocio estacional oscila mucho entre ambos: ServiceNow gana 2.000 M$ de flujo de caja libre en su trimestre de diciembre y 500 M$ en el de junio.
Comparado con el mismo trimestre del año anterior, no con una previsión de analistas. Un «beat» o un «miss» necesita una estimación de consenso, que es un dato licenciado que no tenemos — y equivocarse es peor que dejarlo fuera.
“Third quarter revenue of $1.4 million grew 22% compared to the prior year and 12% sequentially from the second quarter, and we delivered that growth while reducing operating expenses compared to both the third quarter of 2025 and the second quarter of this year,”
Citado literalmente de la publicación, y mostrado solo cuando el informe lo atribuye a una persona con nombre.
Las publicaciones salen antes de la apertura o tras el cierre, así que la ventana va del cierre previo al día del informe al cierre de la sesión siguiente: la reacción queda dentro en ambos casos.
Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the “SI Joint”). The Company has developed The Catamaran ® SI Joint Fusion System (“The Catamaran System”) that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially all the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+ ® SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon has been focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.
La propia descripción de la empresa, tal como aparece al pie de la publicación.
The quote, the company description and the latest quarter come from Tenon Medical’s earnings press release (an Item 2.02 8-K) filed 12 de noviembre de 2026. Earlier quarters come from its quarterly and annual reports, and the latest will be replaced once the official report is filed. Leer la publicación en EDGAR Las cotizaciones están ajustadas por splits y dividendos.
Tenon Medical, Inc reported on 12 de noviembre de 2026. We are fetching the call transcript; its summary follows once the transcript is in.
Just reported
From Tenon Medical, Inc's results release of 12 de noviembre de 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Actual
1,4M US$
+22 % y/y
+12 % q/q
Guided
—
No guide given
Actual
-3,1M US$
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.